Growth Funding InStride Health secured a $30M Series C financing in June 2026, signaling strong investor confidence and potential for scaled partnerships with payers, health systems, and schools seeking proven pediatric anxiety and OCD treatment programs.

Expansion Opportunities The company has already expanded offices in Massachusetts and Connecticut, highlighting a momentum and appetite for geographic growth that sales teams can leverage to partner with additional regional insurers and school districts.

Awarded Innovator Recognition as a Mental Health Innovation Award winner at the 2026 MedTech Breakthrough awards enhances credibility when engaging potential clients and partners, supporting conversations with payers and providers about differentiated care models.

Clinical Focus With a CBT and exposure therapy–driven, family-inclusive care model for youth up to age 22, there is a clear value proposition for payers and integrated delivery networks seeking evidence-based, scalable pediatric mental health solutions.

Leadership & Growth Recent leadership appointments in finance and commercial roles, along with ongoing clinical leadership, suggest a strengthened go-to-market capability and potential for larger contracts with insurers, schools, and health systems.